Click Here to Register

Directions to Mission Bay

For More Information: Contact Douglas Crawford QB3 Associate Executive Director douglas.crawford@ucsf.edu 415-514-4408

The 2nd Annual Collaborative Drug Discovery (CDD) - UCSF Community Meeting for Neglected Disease, Commercial and Orphan Drug Research (a free, 1-day event) on October 7 is the best place for CDD members and scientists from all disciplines to get together, discuss their research projects, and showcase their work to others in the community.

Speakers:

• David Sullivan, MD, Johns Hopkins
• Fred Buckner, MD, University of Washington
  
• Janice Kranz, PhD, Stanley Center for Psychiatric Research, Broad Institute of MIT & Harvard
• Conor Caffrey, PhD, Sandler Center, UCSF
• Jean Claude-Bradley, PhD Dept. of Chemistry, Drexel University
  
• Sean Ekins, PhD, UMDNJ/Collaborations in Chemistry/ Snowdon Pharmaceuticals 
  
• Andrea Altieri, PhD, ASINEX
• Robert Damoiseaux, PhD, UCLA Molecular Screening Shared Resource (MSSR) Center
• Moses Hohman, PhD, Head of Software, Collaborative Drug Discovery (CDD roadmap)
• J. Leighton Read, MD (Alloy Ventures) - Financing Biomedical Innovation from academia to the market:  From FluMist™ to Priority Review Vouchers and other stories
  
• Russell "Rusty" Bromley, Chief Operating Officer, Myelin Repair Foundation
• Adam Renslo, PhD, UC San Francisco
• Scott Lokey, PhD, UC Santa Cruz
• Victoria Hale, PhD, Founder and Chair of the Board, Institute for OneWorld Health
• Catherine Ley, PhD, Director of Virtual Biotech Services, Collabrx
  Wells Whitney, ScD, Lung Cancer Foundation

• Panel #1: What are foundations looking for from Academic researchers?
• Panel #2: What makes collaborations successful within and between groups?
  

• Scientists working in drug discovery
• Researchers who are involved in collaborations or generate complex drug discovery data
• Students who want to learn more about the drug discovery industry
• People who wish to network, establish new or strengthen existing collaborations
• Current CDD community members to set the collaborative platform's future direction
• Anyone interested in new drugs for diseases of the developing world, private public partnerships, and/or global health

Stay for the post-symposium reception from 6 -7pm!